CD4+Hepatic Cancer-Specific Cytotoxic T Lymphocytes in Patients with Hepatocellular Carcinoma

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.

Elizabeth A. Grimm, A Mazumder, H Z Zhang et al. · The Journal of Experimental Medicine · 1982 · 2.2K citations · Full text

Life Sciences, Immunology, Oncology +15

Clonal analysis of human cytotoxic T lymphocytes: T4+ and T8+ effector T cells recognize products of different major histocompatibility complex regions.

S. Meuer, S F Schlossman, E L Reinherz · Proceedings of the National Academy of Sciences · 1982 · 615 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Current Clinical Topics in Infectious Diseases

Archives of Internal Medicine · 1984 · 473 citations

Veterinary Medicine, Infectious Diseases, Microbiology +14

Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor.

K Itoh, Chris D. Platsoucas, Charles M. Balch · The Journal of Experimental Medicine · 1988 · 322 citations · Full text

Life Sciences, Immunology, Oncology +17

Cytotoxic T cells from ovarian malignant tumors can recognize polymorphic epithelial mucin core peptides.

Constantin G. Ioannides, Bryan Fisk, Keith R. Jerome et al. · The Journal of Immunology · 1993 · 211 citations · Full text

Life Sciences, Immunology, Oncology +17